Sager’s Pharmaceuticals Stock Is ‘Stunningly High’ For a New Company
NEW YORK — Sager’s pharmaceuticals is “stunningly high,” according to a recent report by Bloomberg.The biotech company reported a profit of $1.2 billion for the year ended March 31, and analysts said the company had $8 billion in cash.The company’s stock has jumped $1,871 per share since Bloomberg’s report.The stock price is up nearly 60%…